Renal Cancer - Results from #120

Ampullary tumor caused by metastatic renal cell carcinoma, "Beyond the Abstract," by Jiaobo Zhai, MD October 24, 2014

The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma, "Beyond the Abstract," by Sandy Giuliano, Mélanie Guyot, Renaud Grepin, and Gilles Pages October 10, 2014

Efficacy of everolimus in patients with advanced renal cell carcinoma refractory or intolerant to VEGFR-TKIs and safety compared with prior VEGFR-TKI treatment, "Beyond the Abstract," by Renpei Kato, MD August 26, 2014

Two successful cases of the treatment of transitional cell carcinoma involving the renal pelvis in either a functional or anatomical solitary kidney, "Beyond the Abstract," by Bo Yang August 7, 2014

Chemotherapy-mediated p53-dependent DNA damage response in clear cell renal cell carcinoma: Role of the mTORC1/2 and hypoxia-inducible factor pathways, "Beyond the Abstract," by Veronica A. Carroll, PhD July 25, 2014

Adequate immunosuppression and oncological control employing temsirolimus as a base immunosuppressant for a recipient with metastatic renal cancer, "Beyond the Abstract," by Shih-Chieh Jeff Chueh, MD, PhD July 24, 2014

A 10-year, single institution review of renal cell carcinoma with venous neoplastic thrombosis, "Beyond the Abstract," by Giacomo Maria Pirola, MD July 22, 2014

The influence of different tumor enhancement measurement approaches on pretreatment differentiation, by CT, of renal cell carcinoma subtypes, "Beyond the Abstract," by Ivan Žokalj July 12, 2014

A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma, "Beyond the Abstract," by Denis L. Fontes Jardim and David S. Hong June 26, 2014

Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma, "Beyond the Abstract," by Ron Rodriguez, MD, PhD with Christos Georgiades, MD, PhD June 24, 2014

The association between statin medication and progression after surgery for localized renal cell carcinoma, "Beyond the Abstract," by Robert J. Hamilton, MD, MPH, FRCSC June 23, 2014

Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis, "Beyond the Abstract," by Adam Shrewsberry, MD June 20, 2014

A review of the current role of targeted therapy in the treatment of metastatic renal carcinoma, "Beyond the Abstract," by Paulo Jaworski, MD June 17, 2014

Washington University long-term experience with renal cryoablation versus robot-assisted partial nephrectomy, "Beyond the Abstract," by Eric H. Kim, MD June 11, 2014

Renal cancer-selective englerin A induces multiple mechanisms of cell death and autophagy, "Beyond the Abstract," by Ayse Batova, PhD June 6, 2014

A Malaysian single centre perspective of clinical prognostic factors and survival outcome in renal cell carcinoma patients, "Beyond the Abstract," by Ning Yi Yap May 16, 2014

Management of renal cell carcinoma with level I tumor thrombi using a combined retroperitoneoscopic and transperitoneal laparoscopic technique, "Beyond the Abstract," by Oner Sanli and Abubekir Boguk May 14, 2014

A case of bilateral renal cell carcinoma associated with long-term dialysis showing false-positive immunoreactivity for TFE3 as Xp11 translocation renal cell carcinoma, "Beyond the Abstract," by Aiko Kurisaki-Arakawa and Tsuyoshi Saito May 9, 2014

Kidney injury molecule-1 (KIM-1) may become a kidney “prostate specific antigen (PSA)” for renal cell carcinoma, "Beyond the Abstract," by Ping L. Zhang, MD, PhD, FCAP, FASN and Jason M. Hafron, MD April 12, 2014

Sunitinib-treated patients with renal cell carcinoma and benign prostatic hyperplasia expereince shrinkage of prostate volume, "Beyond the Abstract," by Takashi Hatano, MD, PhD March 31, 2014

Page 7 of 11